Search - Prime Therapeutics
Navigate to
-
Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A...
Prime Article: Perspectives -
Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service
PA Sub-Categories: GLP-1 Technology Specialty drugs Prime Article: Perspectives -
AMCP Nexus offers opportunity to nurture next generation of managed care leaders
Prime Article: Stories -
Specialty Pharmacy Continuum
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Drug pricing information All drugs listed on the National Average Drug Acquisition Cost (NADAC) list that are reimbursed at rates either 10% below or 10% above the national average drug...
-
publications Quarterly Drug Approvals: January 2025 This report provides an overview of new drugs and indications approved in 2024 January 31, 2025 Specialty drug approvals Specialty drug...
-
publications Quarterly Drug Approvals: April 2025 This report provides an overview of new drugs and indications approved in 2025 April 24, 2025 Specialty drug approvals Specialty drug approvals -...
-
publications Quarterly Drug Approvals: October 2024 This report provides an overview of new drugs and indications approved in 2024 October 31, 2024 Specialty drug approvals Specialty drug...
-
Connect care for your members with cancer IntegratedRx® – Oncology puts everyone on the same team and gives members a central location for their cancer medicines. Breadcrumb Home Our solutions...
-
Connect care for your members with cystic fibrosis IntegratedRx – Cystic Fibrosis helps deliver an integrated care experience for members and their providers. Breadcrumb Home Our solutions...